Shares of Spire Healthcare (LSE:SPI), a leading UK private hospital operator, jumped more than 4% following reports that major investors are urging the company to explore a potential sale. According to Sky News, activist investment trust Achilles, co-founded by fund manager Christopher Mills, together with other Harwood Capital Management entities holding around 5% of Spire, have encouraged the board to engage with prospective buyers.
Investors argue that Spire is undervalued, noting that its real estate assets alone are estimated at over £1.4 billion, compared with a market capitalization of roughly £820 million. The company operates 38 hospitals and more than 50 clinics, medical centres, and consulting rooms across the UK, making it the country’s largest provider of hip and knee procedures. CEO Justin Ash leads the company, which is chaired by Sir Ian Cheshire.
Achilles, managed by Robert Naylor, has reportedly recommended that Spire appoint advisers to initiate a formal sale process. While no formal approaches have been confirmed, the board has reiterated its commitment to enhancing shareholder value. The push for a sale reflects broader investor interest in UK-listed firms, with multiple FTSE 250 companies attracting attention from private equity and overseas buyers.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Leave a Reply